- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.12.25 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 19.12.2025 | 826 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 19.12.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 19.12.2025ISIN NameCA74349R1055 PROPHECY... ► Artikel lesen | |
| 11.12.25 | NGM MARKET NOTICE: #25-119 Decision on delisting of Diagonal Bio AB from Nordic SME | 5 | Cision News | ||
| DIAGONAL BIO Aktie jetzt für 0€ handeln | |||||
| 11.12.25 | XFRA 9F1: AUSSETZUNG/SUSPENSION | 320 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILDIAGONAL BIO AB... ► Artikel lesen | |
| 11.12.25 | NGM MARKET NOTICE: #25-118 Trading halt in Diagonal Bio AB | 6 | Cision News |
4 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTELLIA THERAPEUTICS | 12,300 | +2,33 % | Intellia Therapeutics, Inc. - 8-K, Current Report | ||
| PACIFIC BIOSCIENCES OF CALIFORNIA | 1,328 | -3,77 % | PacBio to Report First Quarter 2026 Financial Results on May 7, 2026 | ||
| ATAIBECKLEY | 3,560 | +2,89 % | Besonders beachtet! Profitiert Emyria vom Analysten-Hype um MDMA-Branchenriesen AtaiBeckley? | ||
| BIOMERIEUX | 91,25 | +0,38 % | BioMerieux SA Profit Declines In Full Year | PARIS (dpa-AFX) - BioMerieux SA (EYWN.MU) reported earnings for full year that Drops, from the same period last yearThe company's bottom line totaled EUR397.5 million, or EUR3.34 per share.... ► Artikel lesen | |
| BIO GREEN MED SOLUTION | 1,050 | 0,00 % | Bio Green Med Solution kündigt Quartalsdividende für Vorzugsaktien an | ||
| ANAPTYSBIO | 57,76 | +1,65 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 17.04.2026 | Das Instrument PCFG IE00B8JG1787 WITR MU.AS.I.SILV.ETP2062 ETC wird cum Kapitalmassnahme gehandelt am 17.04.2026 und ex Kapitalmassnahme am 20.04.2026 The instrument PCFG IE00B8JG1787 WITR MU.AS.I.SILV.ETP2062... ► Artikel lesen | |
| GENUS | 30,200 | -0,66 % | Genus PLC - Director/PDMR Shareholding | ||
| ABIONYX PHARMA | 3,940 | +5,35 % | ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company's Share Capital | Article L233-8-II of the French Commercial Code
Article 223-16 of the General Regulations of the AMF (French Financial Markets Authority)
Regulatory News:
ABIONYX Pharma (Paris:ABNX):
Market:... ► Artikel lesen | |
| AKESO | 16,250 | +0,34 % | Akeso, Inc.: Akeso Reports Full-Year 2025 Financial Results | HONG KONG, March 26, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced its 2025 annual results, highlighting a year of comprehensive... ► Artikel lesen | |
| MEIRAGTX | 7,900 | -1,86 % | MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP) | Company entered into an asset purchase agreement with Johnson & Johnson (J&J) to acquire all interests in botaretigene sparoparvovec (bota-vec) for the treatment of X-linked retinitis pigmentosa (XLRP)MeiraGTx... ► Artikel lesen | |
| XTL BIOPHARMACEUTICALS | 1,910 | -1,04 % | XFRA HHB0: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| MAAT PHARMA | 5,550 | +0,91 % | MaaT Pharma Announces Publication of Retrospective Data in Third-Line Acute GvHD from the CHRONOS Study in Bone Marrow Transplantation Journal | CHRONOS is one of the largest real-world studies including refractory GI-aGvHD patients (n=59) treated with third-line best available treatments other than microbiome-based therapy
Results... ► Artikel lesen | |
| ISOFOL MEDICAL | 0,051 | +1,18 % | Isofol Medical AB: Isofol optimizes the design of its phase Ib/II study following new regulatory approval | GOTHENBURG, Sweden, April 15, 2026 - Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) today announces that the German regulatory authority BfArM has approved an optimized design for the company's... ► Artikel lesen | |
| APOGEE THERAPEUTICS | 90,55 | 0,00 % | Morning Market Movers: urban-gro, WeShop Holdings, QVC Group, Apogee Therapeutics See Big Swings | OTTAWA (dpa-AFX) - At 8:30 a.m. ET on Monday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| PSYENCE BIOMEDICAL | 5,870 | 0,00 % | Psyence Biomedical Ltd.: Psyence BioMed Announces Export of GMP-Manufactured Natural Psilocybin (NPX-5) to Australia for Ongoing Phase IIb Clinical Trial | NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine... ► Artikel lesen |
DIAGONAL BIO AB gehört der Branche Biotechnologie an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,004 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu DIAGONAL BIO AB finden Sie auf Wallstreet Online.